Precision Medicine Market Share, Trends, Development Strategies, Competitive Scenario and Segmentation Analysis 2030

Comments · 43 Views

Data Bridge Market Research analyses that the precision medicine market, which was USD 7.33 billion in 2022, would rise to USD 114.54 billion by 2030 and is expected to undergo a CAGR of 12.6% during the forecast period 2023 to 2030.

Data Bridge Market Research analyses that the precision medicine market, which was USD 7.33 billion in 2022, would rise to USD 114.54 billion by 2030 and is expected to undergo a CAGR of 12.6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market research analysis data included in this report lend a hand to businesses for planning of strategies related to investment, revenue generation, production, product launches, costing, inventory, purchasing and marketing. What's more Precision Medicine Market report presents the data and information for actionable, most recent and real-time market insights which makes it easier to even take critical business decisions.

Download Copy of this Report to understand structure of the complete @ https://www.databridgemarketresearch.com/reports/global-precision-medicine-market

Market Definition:

Precision medicine is a type of medical approach for disease prevention and diagnosis which is based on environmental, genetic, and behavioral variability. It helps predict illness susceptibility, diagnosis and progression, and prescription medicine. Precision medicine is also frequently used to identify chromosomal abnormalities in the fetus and cancer, direct therapy for chronic diseases, and identify the risk of passing genetic problems by minimizing pharmaceutical clinical studies' time, expense, and failure rate.

Market Overview:

Precision medicine is the latest disease prevention and treatment approach that is gaining much popularity. Several initiatives, such as Precision Medicine Initiative (PMI), were announced in 2015, with more than one million volunteers taking place to apply precision medicine to all disorders. Different types of innovation and the wide availability of new technology are other major factors for the market's growth.

Market Scope and Size:

Application

  • Diagnostics
  • Therapeutics
  • Others

Technologies

  • Pharmacogenomics
  • Point-of-Care Testing
  • Stem Cell Therapy
  • Pharmacoproteomics
  • Others

Indication

  • Oncology
  • Central Nervous System (CNS) Disorders
  • Immunology Disorders
  • Respiratory Disorders
  • Others

Drugs

  • Alectinib
  • Osimertinib
  • Mepolizumab
  • Aripiprazole Lauroxil,
  • Others

Route of Administration

  • Oral
  • Injectable

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Country Level Analysis:

The countries covered in the precision medicine market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Key Players:

Some of the major players operating in the precision medicine market are:

  • Moderna, Inc. (U.S.)
  • Personalis, Inc. (U.S.)
  • CureVac SE (Germany)
  • Celldex Therapeutics (U.S.)
  • BioNTech SE (Germany)
  • Advaxis, Inc. (U.S.)
  • Agenus Inc. (U.S.)
  • Immatics Biotechnologies GmbH (Germany)
  • Gritstone Oncology (U.S.)
  • ImmunityBio, Inc. (U.S.)
  • bioMérieux SA (France)
  • Bayer AG (Germany)
  • Pfizer Inc. (U.S.)
  • GSK plc (U.K.)
  • F. Hoffmann-La Roche Ltd. (Switzerland)

Download Sample PDF Copy of this Report to understand structure of the complete report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-precision-medicine-market

TABLE OF CONTENTS:

Part 01: Executive Summary

Part 02: Scope of the Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Pipeline Analysis

Part 06: Market Sizing

Continue………

Browse Trending Reports:

About Data Bridge Market Research:

An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.

Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.

Contact Us: -

Data Bridge Market Research

US: +1 888 387 2818

United Kingdom: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: – sopan.gedam@databridgemarketresearch.com

 

 

Comments